Medical Device News Magazine

Jupiter Medical Center Establishes Command Center to Bolster COVID-19 Preparedness

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Since January, Jupiter Medical Center’s medical staff leadership, infection prevention experts and executive team have been developing plans to screen, isolate and treat COVID-19 patients, including conducting drills and training for hospital team members and ensuring the careful stewardship of equipment and supplies.

Jupiter Medical Center was one of the first hospitals to implement CDC guidelines for the screening, diagnosis, and treatment of COVID-19 and since has also been working closely with the Florida Department of Health to strictly adhere to state and federal guidelines.

To streamline and centralize hospital operations in order to address an expected increase in patient volume of COVID-19 patients, Jupiter Medical Center has established an Incident Command Center. Similar to the actions the regional medical center would take during a hurricane, the command center offers a dedicated structure to streamline communication and provide administrative oversight to manage patient treatment, clinical staffing, and the allocation of rooms, equipment and supplies.

“Consistent with leading national and regional hospitals across the country, we implemented a series of comprehensive measures early to improve our readiness,” said Dr. Amit Rastogi, president and chief executive officer. “In addition to strictly adhering to CDC guidelines, we initiated additional preventive measures and began multidisciplinary training to prepare our team members to recognize and screen potential cases, implement isolation protocols, and properly use personal protective equipment (PPE) while treating patients,” Dr. Rastogi continued.

The regional medical center also confirmed that it is starting to see patients who have tested positive for COVID-19. As required by federal privacy laws, Jupiter Medical Center is prevented from releasing any personal details about patients undergoing treatment.

Most recently, the medical center adopted The American College of Surgeons’ recommendations and began rescheduling non-urgent, elective surgeries to increase capacity and minimize the potential of COVID-19 exposure among patients, team members, and frontline providers.

“We will continue to perform nonelective, urgent and emergency surgeries,” Dr. Rastogi said. “However, by reducing the number of elective procedures, we are able to conserve our supply of personal protective equipment, beds, and ventilators for use in patients with critical illnesses, and ensure that more of our clinical team members are available to care for patients who are most in need when the time comes.”

Jupiter Medical Center is not a designated COVID-19 testing site, in accordance with directives from the Florida Department of Health. Public health authorities have advised that hospitals should not be used for non-critical conditions or non-emergencies, including coronavirus testing. Individuals experiencing symptoms – fever, cough or difficulty breathing – are urged to call their physician or contact one of several state-designated testing sites that are equipped to take swabs for testing and send them to the appropriate lab.

The medical center continues to engage national and regional suppliers to procure additional resources and supplies, such as test kits, N95 respirator masks, and ventilators, to identify and treat those who may require hospitalization. In addition to implementing the necessary personal protective equipment (PPE) to protect frontline caregivers, Jupiter Medical Center is leveraging the use of Tru-D SmartUVC ultra-violet disinfection robots that deconstruct the DNA of deadly pathogens and eliminate common health care-associated infection culprits.

Jupiter Medical Center has implemented a ‘no visitation’ policy with the exception of Labor & Delivery and Pediatric patients, who will be permitted one visitor. While the hospital recognizes this policy is highly inconvenient for patients and their loved ones, it is becoming necessary to reduce the likelihood of exposure.

The medical center has temporarily suspended health and wellness classes, professional CME and community events. Volunteer services and the hospital’s Motor Aid patient transport system also have been suspended.

If you or a loved one are exhibiting symptoms of COVID-19, members of the public are advised to call their primary care provider (PCP) for a screening. Or you may call the Florida Department of Health’s COVID-19 hotline which is available 24 hours a day and 7 days a week at 1 (866) 779-6121.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.